Karanjin

CAS No. 521-88-0

Karanjin ( —— )

Catalog No. M24497 CAS No. 521-88-0

Karanjin is a flavonoid?obtained from the seeds of the karanja tree.Karanjin induces GLUT4 translocation in skeletal muscle cells by increasing AMPK activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 88 In Stock
10MG 155 In Stock
25MG 259 In Stock
50MG 390 In Stock
100MG 565 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Karanjin
  • Note
    Research use only, not for human use.
  • Brief Description
    Karanjin is a flavonoid?obtained from the seeds of the karanja tree.Karanjin induces GLUT4 translocation in skeletal muscle cells by increasing AMPK activity.
  • Description
    Karanjin is a flavonoid?obtained from the seeds of the karanja tree.Karanjin induces GLUT4 translocation in skeletal muscle cells by increasing AMPK activity.?Karanjin can induce cancer cell death through cell cycle arrest and enhance apoptosis.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    521-88-0
  • Formula Weight
    292.3
  • Molecular Formula
    C18H12O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C1C(OC)=C(C2=CC=CC=C2)OC3=C1C=CC4=C3C=CO4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Larvicidal activity and possible mode of action of four flavonoids and two fatty acids identified in Millettia pinnata seed toward three mosquito species. Parasit Vectors. 2015 Apr 19;8:237.
molnova catalog
related products
  • GSK621

    GSK621 (GSK-621) is a potent, specific AMPK agonist (activator), induces cytotoxicity in AML (IC50=13-30 uM).

  • Metformin hydrochlor...

    Metformin Hcl, a widely used anti-diabetic drug has potential efficacy as an anti-Y drug.

  • ZLN-024

    A novel AMPK allosteric activator that has no effect on mitochondrial function or the ADP/ATP ratio; directly activate recombinant AMPK α1β1γ1 and its homologue α2β1γ1 with EC50 of 0.42 uM and 0.95 uM, respectively.